|
|
Volumn 11, Issue 3, 1996, Pages 327-329
|
|
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBIDOPA PLUS LEVODOPA;
DOPAMINE RECEPTOR STIMULATING AGENT;
PERGOLIDE;
ADULT;
AGED;
CLINICAL ARTICLE;
DYSKINESIA;
FEMALE;
HUMAN;
LETTER;
MALE;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
AGED;
ANTIPARKINSON AGENTS;
CARBIDOPA;
DOPAMINE AGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
DYSKINESIA, DRUG-INDUCED;
FEMALE;
HUMANS;
LEVODOPA;
MALE;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
PERGOLIDE;
|
|
EID: 0029936417
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/mds.870110319 Document Type: Letter |
|
Times cited : (70)
|
|
References (0)
|
